these small bios are very easily manipulated, reminds me of RPTP when it was in the mid 5's back in Jan. and promptly dropped to the mid 4's scaring folks out of their shares, its over $6 today moving into its catalysts, so watch for the games, add on any big dips and wait for the catalysts....
Totally Agree with you Jefferson
It is kind of frustrating, but it is what it is.
I would say in about two weeks this will begin to it's ADCOM run and then it will continue post-adcom in May.
People will be surprised that this WILL be approved. I have traded DCTH for years. I recall when $5.00 was my target price...I keep getting emails from yahoo saying DCTH is below your target of $5.00. This was of course prior to them getting their sh_t together and debacles with the FDA.
There are a lot of people who do not see the potential in this one and it is flying under the radar right now.
The ADCOM is May 2. Occular Melanoma that has been spread to the liver is a death sentence and this can significantly help prolong life.
Life is what we all love. Look, this is a Death Sentence, if it helps more people than it hurts, then it is a No Brainer.
This has been well studied and regardless of what and how people think, this is the one that will break AF's low market cap "non-approval" streak.
Mark it down, AF.